Parenteral nutrition (PN) is a life-sustaining therapy providing nutrients to individuals with impaired intestinal tract function and enteral access challenges. It is one of the most complex prescriptions written routinely in the hospital and home care settings. This article is to aid the nutrition support clinician in the safe provision of PN, including selecting appropriate patients for PN, vascular access, development of a PN admixture, appropriate therapy monitoring, recognition of preparation options, and awareness of preparation and stability concerns.
DudrickSJWilmoreDWVarsHMRhoadsJE.Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968;64(1):134-142.
2.
BoullataJIGilbertKSacksGS. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling and dispensing. JPEN J Parenter Enteral Nutr. 2014;38:334-377.
3.
GuenterPBoullataJIAyerP. Standardized competencies for parenteral nutrition prescribing: the A.S.P.E.N. model. Nutr Clin Pract. 2015;30(4):570-576.
4.
KrzywdaEAAndrisDAEdmistonCE. Parenteral access devices. In: MuellerC, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2012:269.
5.
MirtalloJCanadaTJohnsonD. Task force for the revision of safe practices for parenteral nutrition: safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28(6):S39-S70.
6.
NormanKPichardCLochsHPirlichM.Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27(1):5-15.
7.
McClaveSATaylorBEMartindaleRG. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenteral Enteral Nutr. 2016;40(2):159-211.
8.
VinkenAGBathalonGPSawayaALDallalGETuckerKLRobertsSB.Equations for predicting the energy requirements for healthy adults aged 18-81y. Am J Clin Nutr. 1999;69(5):920-926.
9.
OwaisAEKabirSIMcnaughtCGattMMacfieJ.A single-blinded randomised clinical trial of permissive underfeeding in patients requiring parenteral nutrition. Clin Nutr. 2014;33:997-1001.
10.
DickersonRN.Hypocaloric, high-protein nutrition therapy for critically ill patients with obesity. Nutr Clin Pract. 2014;29(6):786-791.
11.
ChobanPDickersonRMaloneA. A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity. JPEN J Parenter Enteral Nutr. 2013;37:714-744.
12.
BrownROCompherC; American Society for Parenteral and Enteral Nutrition Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010;34(4):366-377.
13.
DickersonRN.Hypocaloric feeding of obese patients in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2005;8:189-169.
14.
BostRBTjanDHvan ZantenAR.Timing of (supplemental) parenteral nutrition in critically ill patients: a systematic review. Ann Intensive Care. 2014;4(31):1-13.
15.
CahillNEMurchLJeejeebhoyK. When early enteral feeding is not possible in critically ill patients: results of a multicenter observational study. JPEN J Parenter Enteral Nutr. 2011;35(2):160-168.
16.
CasaerMPMesottenDHermansG. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(6):506-517.
17.
DoigGSSimpsonFSweetmanEA. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: A randomized controlled trial. JAMA. 2013;309(20):2130-2138.
18.
HeideggerCPBergerMMGrafS. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013;381(9864):385-393.
KumpfVJMirtalloJMPetersenC. Parenteral nutrition formulations: preparation and ordering. In: MerrittR, ed. The ASPEN Nutrition Support Practice Manual. 2nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2005:97-107.
21.
KearnsLRPhillipsMCNess-AbramofRApovianCM.Update on parenteral amino acids. Nutr Clin Pract. 2001;16:219-225.
B Braun Medical. Amino acid solutions product information (specialty and standard). http://bbraunusa.com/. Accessed March 1, 2015.
24.
Hospira. Amino acid product information. http://hospira.com/. Accessed March 1, 2015.
25.
SingerPBergerMMVan den BergheG. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009;28:387-400.
26.
CalderPCJensenGLKoletzkoBVSingerPWantenGJ.Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010;36(5):735-749.
GrimmHTibellANorrlindBBlecherCWilkerSSchwemmieK.Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr. 1994;18(5):417-421.
33.
KinsellaJELokeshB.Dietary lipids, eicosanoids, and the immune system. Crit Care Med. 1990;18(2)(suppl):S94-S113.
34.
BattistellaFDWidergrenJTAndersonJTSieplerJKWeberJCMacCollK.A prospective, randomized trial of intravenous fat emulsion administration trauma victims requiring total parenteral nutrition. J Trauma. 1997;43(1):52-60.
35.
McCowenKCFrielCSternbergJ. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications. A randomized clinical trial. Crit Care Med. 2000;28(11):3606-3611.
36.
GouletOde PotterSAnte’biH. Long-term efficacy and safety of a new olive oil–based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr. 1999;70(3):338-345.
GranatoDBlumSRössleCLe BoucherJMalnoëADutotG.Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. JPEN J Parenter Enteral Nutr. 2000;24(2):113-118.
39.
Cury-BoaventuraMFGorjãoRde LimaTMNewsholmePCuriR.Comparative toxicity of oleic and linoleic acid on human lymphocytes. Life Sci. 2006;78(13):1448-1456.
40.
EdmundsCEBrodyRAParrottJSStankorbSMHeylandDK.The effect of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med. 2014;42(5):1168-1177.
41.
UmpierrezGESpiegelmanRZhaoV. A double-blind, randomized clinical trial comparing soybean oil–based versus olive oil–based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med. 2012;40(6):1792-1798.
42.
SiqueiraJSmileyDNewtonC. Substitution of standard soybean oil with olive oil–based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab. 2011;96(10):3207-3216.
43.
BarberJRSackGS. Parenteral Nutrition Formulations In: MuellerCM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2012:245-264.
M.V.I. Adult [package insert]. Lake Forest, IL: Hospira; revised September2014.
47.
M.V.I.-12 [package insert]. Lake Forest, IL: Hospira, revised September2014.
48.
VanekVWBorumPBuchmanA. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012;27(4):440-491.
49.
FesslerT.Trace elements in parenteral nutrition: a practice guide for dosing and monitoring for adult patients. Nutr Clin Pract. 2013;28(6):722-729.
50.
Pluhator-MurtonMMFedorakRNAudetteRJMarriageBJYatscoffRWGramlichLM.Trace element contamination of total parenteral nutrition: contribution of component solutions. JPEN J Parenter Enteral Nutr. 1999;23(4):222-227.
51.
SlatteryERumoreMMDouglasJSSeresDS.3-in-1 vs 2-in-1 parenteral nutrition in adults: a review. Nutr Clin Pract. 2014;29(5):631-635.
52.
HassigTBMcKinzieBPFortierCRTaberD.Clinical management strategies and implications for parenteral nutrition drug shortages in adult patients. Pharmacotherapy. 2014;34(1):72-84.
53.
McMahonMMNystromEBraunschweigCMilesJCompherC.A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013;37(1):23-36.
54.
SackGSMayhewSJohnsonD. Parenteral nutrition implementation and management. In: MerrittR, ed. The A.S.P.E.N. Nutrition Support Practice Manual. 2nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2005:108-117.
55.
McMahonMM.Management of parenteral nutrition in acutely ill patients with hyperglycemia. Nutr Clin Pract. 2004;19(2):120-128.
56.
MirtalloJMPatelM. Overview of parenteral nutrition. In: MuellerCMKovacevichDSMcClaveSAMillerSJSchwartzDB, eds. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2012:234-244.
57.
KraftMD.Phosphorus and calcium: a review for the adult nutrition support clinician. Nutr Clin Pract. 2015;30(1):21-33.
58.
CheugNWNapierBZaccariaCFletcherJP.Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28(10):2367-2371.
59.
GosmanovARUmpierrezGE.Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diabetes Rep. 2013;13(1):155-162.
60.
OlveiraGTapiaMJOconJ. Parenteral nutrition–associated hyperglycemia in non-critically ill inpatients increases the risk of in hospital mortality (multicenter study). Diabetes Care. 2013;36(5):1061-1066.
61.
JakobyMGNannapaneniN.An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JPEN J Parenter Enteral Nutr. 2012;36(2):183-188.
62.
ValeroMALeon-SanzMEscobarIGomisPdelaCámaraAMorenoJM.Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr. 2001;55(12):1111-1116.
63.
HongsermeierTBistrianBR.Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1993;17(1):16-19.
64.
OlveiraGTapiaMJOconJ. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. Nutrition. 2015;31:58-63.
65.
WagmanLDNewsomeHHMillerKBThomasRBWeirGC.The effect of acute discontinuation of total parenteral nutrition. Ann Surg. 1986;204(5):524-529.
66.
NirulaRYamadaKWaxmanK.The effect of abrupt cessation of total parenteral nutrition on serum glucose: a randomized trial. Am Surg. 2000;66(9):866-869.
67.
BistrianBR.Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads lecture. JPEN J Parenter Enteral Nutr. 2003;27(3):168-175.
68.
O’NeillJACaldwellMDMengHC.Essential fatty acid deficiency in surgical patients. Ann Surg. 1977;185(5):535-542.
HamiltonCAustinTSeidnerDL.Essential fatty acid deficiency in human adults during parenteral nutrition. Nutr Clin Pract. 2006;21(4):387-94.
71.
MirtalloJMDastaJFKleinschmidtKCVaronJ.State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother. 2010;44(4):688-700.
72.
Mateu-de AntonioJFlorit-SuredaM. New strategy to reduce hypertriglyceridemia during parenteral nutrition while maintaining energy intake [published online September11, 2014]. JPEN J Parenter Enteral Nutr.
73.
LlopJSabinPGarauM. The importance of clinical factors in parenteral nutrition–associated hypertriglyceridemia. Clin Nutr. 2003;22(6):577-583.
74.
KraftMBtaicheIFSacksGS.Review of refeeding syndrome. Nutr Clin Pract. 2005;20(6):625-633.
75.
MehannaHNankivellPCMoledinaJTravisJ.Refeeding syndrome—awareness, prevention and management. Head Neck Oncol. 2009;1:4.
76.
CrookMA.Refeeding syndrome: problems with definition and management. Nutrition. 2014;30(11-12):1448-1455.
77.
TillmanEM.Review and clinical update on parenteral nutrition–associated liver disease. Nutr Clin Pract. 2013;28(1):30-39.
78.
KumpfVJ.Parenteral nutrition–associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21:279-290.
79.
GuglielmiFWBoggio-BertinetDFedericoA. Total parenteral nutrition–related gastroenterological complications. Dig Liver Dis. 2006;38(6):623-642.
80.
EllegardLSunessonABoasaeusI.High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin Nutr. 2005;24:415-420.
81.
CalderPC.Hot topics in parenteral nutrition: rationales for using new lipid emulsion in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc. 2009;68:252-260.
82.
CavicchiMBeauPCrennPDegottCMessingB.Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132(7):525-532.
83.
ShikeMShilsMEHellerA. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. Am J Clin Nutr. 1986;44(1):89-98.
84.
HamiltonCSeidnerDL.Metabolic bone disease in the patient on long-term parenteral nutrition. Pract Gastroenterol. 2008;58:18-32.
GuraKM.Aluminum contamination in products used in parenteral nutrition: has anything changed?Nutrition. 2010;26(6):585-594.
87.
DerenskiK. Adult parenteral nutrition. In: MurdaughLB, ed. Competence Assessment Tools for Health Systems Pharmacists. 5th ed.Bethesda, MD: ASHP; 2015:505-532.
88.
Pontes-ArrudaADos SantosMCMartinsLF. Influence of parenteral nutrition delivery system on the development of bloodstream infections in critically ill patients: an international, multicenter, prospective, open-label, controlled study—EPICOS study. JPEN J Parenter Enteral Nutr. 2012;36(5):574-586.
89.
GuerinKWagnerJRainsKBessesenM.Reduction in central line–associated bloodstream infections by implementation of a post insertion care bundle. Am J Infect Control. 2010;38(6):430-433.
90.
Durand-ZaleskiIDelaunayLLangeronOBeldaEAstierABrun-BuissonC.Infection risk and cost effectiveness of commercial bags or glass bottles for total parenteral nutrition. Infect Control Hosp Epidemiol. 1997;18(3):183-188.
91.
JensenGLMascioliEASeidnerDL. Parenteral infusion of long and medium-chain triglycerides and reticuloendothelial system function in man. JPEN J Parenter Enteral Nutr. 1990;14(5):467-471.
92.
DriscollDF.Total nutrient admixtures: theory and practice. Nutr Clin Pract. 1995;10(3):114-119.
93.
BenoitEEckertPTheytazCJoris-FrasserenMFaouziMBeneyJ.Streamlining the medication process improves safety in the intensive care unit. Acta Anaesthesiol Scand. 2012;56(8):966-975.
94.
MellyMAMengHCSchaffnerW.Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975;110(12):1479-1481.
95.
KimCHLewisDEKumarA.Bacterial and fungal growth in intravenous fat emulsions. Am J Hosp Pharm. 1983;40(12):2159-2161.
96.
O’GradyNPAlexanderMDellingerEP. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-10):1-29.
97.
RoweCEFukuyamaTTMartinoffJT.Growth of microorganisms in total nutrient admixtures. Drug Intell Clin Pharm. 1987;21(7-8):633-638.
98.
VasilakisAApelgrenKN.Answering the fat emulsion contamination question: three in one admixture vs conventional total parenteral nutrition in a clinical setting. JPEN J Parenter Enteral Nutr. 1988;12(4):356-359.
99.
U.S. Food and Drug administration. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm. 1994;51:427-428.
100.
BlackCDPopovichNG.A study of intravenous emulsion compatibility effects of dextrose amino acids and selected electrolytes. Drug Intell Clin Pharm. 1981;15(3):184-193.
101.
PoundsTLovettAEngSIqbalKOrijaIChmielewskiJ.Evaluation of efficacy and safety of premixed parenteral nutrition versus customized parenteral nutrition in a large teaching hospital. Adv Pharmacol Pharm. 2013;1(2):68-73.
102.
MuhlebachS.Practical aspects of multichamber bags for total parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2005;8(3):291-295.
103.
DeLeggeMH.Parenteral nutrition therapy over the next 5-10 years: where are we heading?JPEN J Parenteral Enteral Nutr. 2012;36(2)(suppl):56S-61S.
104.
GervasioJ.Compounding vs standardized commercial parenteral nutrition product: pros and cons. JPEN J Parenteral Enteral Nutr. 2012;36(2)(suppl):40S-41S.
105.
TurpinRCanadaRLiuFXMercaldiCJPontes-ArrudaAWischmeyerP.Nutritional therapy cost analysis in the US: premixed multi-chamber bag versus compounded parenteral nutrition. Appl Health Econ Health Pol. 2011;9(5):281-292.
106.
MillerSJ.Commercial premixed parenteral nutrition: is it right for your institution?Nutr Clin Pract. 2009;24(4):459-469.
TurpinRCanadaTRosenthalV. Bloodstream infection associated with parenteral nutrition preparations methods in the United States: a retrospective, large database analysis. JPEN J Parenter Enteral Nutr. 2012;36(2):169-176.
112.
PichardCMuhlebachSMaisonneuveNSierroC.Prospective survey of parenteral nutrition in Switzerland: a three-year nationwide survey. Clin Nutr. 2001;20(4):345-350.
113.
HayesEMOonardBECohenKRLaulettaJRuggieroR.Customized parenteral nutrition solutions: a comparison of serum electrolytes. Pharm Ther. 2000;25:78-87.
114.
Oxford Parenteral Nutrition Team. Total parenteral nutrition: value of standard feeding regimen. Br Med J. 1983;286:1323-1327.
115.
RuanoMRecuencoITorrecillaA. Standard formulas of parenteral nutrition: a study of their use in general hospital. Nutr Hosp. 1993;8(4):242-248.
116.
PichardCSchwarzGFreiA. Economic investigation of the use of three-compartment total parenteral nutrition bag: prospective randomized unblinded controlled study. Clin Nutr. 2000;19(4):245-251.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
